1-4 of 4
Wan Qin Chong
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract PO-008: Association of plasma Epstein-Barr virus DNA and clinical response in patients with recurrent and/or metastatic nasopharyngeal cancer treated with pembrolizumab or standard-of-care chemotherapy in KEYNOTE-122

Anthony T. C. Chan, Victor Ho Fun Lee, Ruey-Long Hong, Myung-Ju Ahn, Wan Qin Chong, Anna Spreafico, Sung-Bae Kim, Gwo Fuang Ho, Priscilla B. Caguioa, Nuttapong Ngamphaiboon, Ramona F. Swaby, Bo Wei, Andrea Webber, John Kang, Burak Gumuscu, Jianda Yuan, Lillian Siu
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (18_Supplement): PO-008.
https://doi.org/10.1158/1557-3265.AACRAHNS23-PO-008
Published: 15 September 2023
View article titled, Abstract PO-008: Association of plasma Epstein-Barr virus DNA and clinical response in patients with recurrent and/or metastatic nasopharyngeal cancer treated with pembrolizumab or standard-of-care chemotherapy in KEYNOTE-122
Journal Articles

Phase Ib/II Dose Expansion Study of Lenvatinib Combined with Letrozole in Postmenopausal Women with Hormone Receptor–Positive Breast Cancer

Joline S.J. Lim, Andrea L.A. Wong, Samuel G.W. Ow, Natalie Y.L. Ngoi, Gloria H.J. Chan, Yvonne L.E. Ang, Wan Qin Chong, Siew Eng Lim, Yi Wan Lim, Matilda Lee, Joan R.E. Choo, Hon Lyn Tan, Wei Peng Yong, Ross A. Soo, David S.P. Tan, Cheng Ean Chee, Raghav Sundar, Kritika Yadav, Supriya Jain, Lingzhi Wang, Bee Choo Tai, Boon Cher Goh, Soo-Chin Lee
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (11): 2248–2256.
https://doi.org/10.1158/1078-0432.CCR-21-4179
Published: 01 June 2022
View article titled, Phase Ib/II Dose Expansion Study of Lenvatinib Combined with Letrozole in Postmenopausal Women with Hormone Receptor–Positive Breast Cancer
Open the PDF for Phase Ib/II Dose Expansion Study of Lenvatinib Combined with Letrozole in Postmenopausal Women with Hormone Receptor–Positive Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Integration of Antiangiogenic Therapy with Cisplatin and Gemcitabine Chemotherapy in Patients with Nasopharyngeal Carcinoma

Wan Qin Chong, Chwee Ming Lim, Arvind Kumar Sinha, Chee Seng Tan, Gloria Hui Jia Chan, Yiqing Huang, Nesaretnam Barr Kumarakulasinghe, Raghav Sundar, Anand D. Jeyasekharan, Woei Shyang Loh, Joshua K. Tay, Kritika Yadav, Lingzhi Wang, Andrea L. Wong, Li Ren Kong, Ross Andrew Soo, Jieying Amelia Lau, Yu Yang Soon, Robby Miguel Goh, Francis Cho Hao Ho, Siew Meng Chong, Soo Chin Lee, Kwok Seng Loh, Bee Choo Tai, Yaw Chyn Lim, Boon Cher Goh
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (20): 5320–5328.
https://doi.org/10.1158/1078-0432.CCR-20-1727
Published: 15 October 2020
View article titled, Integration of Antiangiogenic Therapy with Cisplatin and Gemcitabine Chemotherapy in Patients with Nasopharyngeal Carcinoma
Open the PDF for Integration of Antiangiogenic Therapy with Cisplatin and Gemcitabine Chemotherapy in Patients with Nasopharyngeal Carcinoma in another window
Includes: Supplementary data
Journal Articles

Phase I Trial of Expanded, Activated Autologous NK-cell Infusions with Trastuzumab in Patients with HER2-positive Cancers

Soo-Chin Lee, Noriko Shimasaki, Joline S.J. Lim, Andrea Wong, Kritika Yadav, Wei Peng Yong, Lip Kun Tan, Liang Piu Koh, Michelle L.M. Poon, Sing Huang Tan, Samuel G.W. Ow, Lavina Bharwani, Yoon Sim Yap, Mabel Z.Q. Foo, Elaine Coustan-Smith, Raghav Sundar, Hon Lyn Tan, Wan Qin Chong, Nesaretnam Barr Kumarakulasinghe, Jedidah L.M. Lieow, Priscillia J.X. Koe, Boon Cher Goh, Dario Campana
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (17): 4494–4502.
https://doi.org/10.1158/1078-0432.CCR-20-0768
Published: 01 September 2020
View article titled, Phase I Trial of Expanded, Activated Autologous NK-cell Infusions with Trastuzumab in Patients with HER2-positive Cancers
Open the PDF for Phase I Trial of Expanded, Activated Autologous NK-cell Infusions with Trastuzumab in Patients with HER2-positive Cancers in another window
Includes: Supplementary data